KERX Financial Facts

Other general and administrative: 4.88M
Income taxes: 0
See Full Income Statement

Total liabilities: 15.37M
Total assets: -191.95M
See Full Balance Sheet

Keryx Biopharmaceuticals Inc. (KERX) Earnings

  |   Expand Research on KERX
Next EPS Date 7/31/14 *Est. EPS Growth Rate -400.0% *Last Qtr.
Average EPS % Beat Rate -57.9% Revenue Growth Rate +42.9% *Last Qtr.
Average % Move 1-Wk after EPS +1.4% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/8/14 Q114 -$0.15-$0.08 -$0.07$10M$9.91M N/A Details
3/12/14 Q413 -$0.21-$0.16 -$0.05N/A$2.22M N/A Details
11/4/13 Q313 -$0.19-$0.11 -$0.08N/A$2.22M N/A Details
7/31/13 Q213 -$0.14-$0.10 -$0.04N/AN/A N/A Details
5/7/13 Q113 -$0.03-$0.01 -$0.02$7M$5.83M N/A Details
3/11/13 Q412 -$0.09-$0.08 -$0.01N/AN/A N/A Details
11/8/12 Q312 -$0.08-$0.07 -$0.01N/AN/A N/A Details
8/7/12 Q212 -$0.02-$0.09 +$0.07N/AN/A N/A Details